Drug-induced changes in monoamine levels in the sympathetic adrenergic ganglion cells and terminals. A histochemical study.
D006916:5-Hydroxytryptophan / Q000494:pharmacology*; D000818:Animals; D002395:Catecholamines / Q000378:metabolism*; D004295:Dihydroxyphenylalanine / Q000494:pharmacology*; D004298:Dopamine / Q000494:pharmacology*; D004809:Ephedrine / Q000494:pharmacology*; D005725:Ganglia, Autonomic / Q000378:metabolism*; D006834:Hydrazines / Q000494:pharmacology*; D008750:Methyldopa / Q000494:pharmacology*; D008856:Microscopy, Fluorescence; D009411:Nerve Endings / Q000378:metabolism*; D009448:Neurochemistry; D009526:Nialamide / Q000494:pharmacology*; D010293:Pargyline / Q000494:pharmacology*; D051381:Rats; D012110:Reserpine / Q000494:pharmacology*; D014191:Tranylcypromine / Q000494:pharmacology*; D014443:Tyrosine / Q000494:pharmacology*
D002395:Catecholamines; D006834:Hydrazines; D014191:Tranylcypromine; D014443:Tyrosine; D008750:Methyldopa; D004295:Dihydroxyphenylalanine; D012110:Reserpine; D010293:Pargyline; D006916:5-Hydroxytryptophan; D004809:Ephedrine; D009526:Nialamide; D004298:Dopamine